Literature DB >> 7937542

Polystyrene-poly (ethylene glycol) (PS-PEG2000) particles as model systems for site specific drug delivery. 2. The effect of PEG surface density on the in vitro cell interaction and in vivo biodistribution.

S E Dunn1, A Brindley, S S Davis, M C Davies, L Illum.   

Abstract

The effect of differing densities of poly (ethylene glycol-2000) (PEG2000) at the particle surface of polystyrene-poly (ethylene glycol-2000) (PS-PEG2000) particles was assessed in terms of hydrophobic interaction chromatography (HIC) and the in vitro and in vivo behaviour of the particles. The particles, with different surface densities of PEG, were prepared by varying the copolymerizing reaction of styrene with a PEG macromonomer. There is a clear relationship between the surface density of PEG as determined by X-ray photoelectron spectroscopy and surface hydrophobicity as assessed by hydrophobic interaction chromatography (HIC). Similarly, the interaction of the particles with non-parenchymal liver cells in in vitro studies was shown to decrease as the surface density of PEG increases. The in vivo study investigating the biodistribution of the PS-PEG particles after intravenous injection into rats reveals that a relationship exists between the surface density of PEG and the extent to which the particles remain in the circulation, avoiding recognition by the reticuloendothelial system. Particles with the higher surface densities show increased circulatory times which compared well with data for particles prepared with the surface adsorbed PEO-PPO block copolymer, Poloxamine 908.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7937542     DOI: 10.1023/a:1018939521589

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  22 in total

1.  The polyoxyethylene/polyoxypropylene block co-polymer poloxamer-407 selectively redirects intravenously injected microspheres to sinusoidal endothelial cells of rabbit bone marrow.

Authors:  C J Porter; S M Moghimi; L Illum; S S Davis
Journal:  FEBS Lett       Date:  1992-06-22       Impact factor: 4.124

2.  Clinical application of antithrombogenic hydrogel with long poly(ethylene oxide) chains.

Authors:  S Nagaoka; A Nakao
Journal:  Biomaterials       Date:  1990-03       Impact factor: 12.479

3.  Protein-resistant surfaces prepared by PEO-containing block copolymer surfactants.

Authors:  J H Lee; J Kopecek; J D Andrade
Journal:  J Biomed Mater Res       Date:  1989-03

4.  Surface characteristics and the interaction of colloidal particles with mouse peritoneal macrophages.

Authors:  L Illum; L O Jacobsen; R H Müller; E Mak; S S Davis
Journal:  Biomaterials       Date:  1987-03       Impact factor: 12.479

5.  Release from alveolar macrophages of an inhibitor of phagocytosis.

Authors:  F Ulrich; D B Zilversmit
Journal:  Am J Physiol       Date:  1970-04

6.  Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo.

Authors:  A Mori; A L Klibanov; V P Torchilin; L Huang
Journal:  FEBS Lett       Date:  1991-06-24       Impact factor: 4.124

7.  Effect of molecular weight in amphipathic polyethyleneglycol on prolonging the circulation time of large unilamellar liposomes.

Authors:  K Maruyama; T Yuda; A Okamoto; C Ishikura; S Kojima; M Iwatsuru
Journal:  Chem Pharm Bull (Tokyo)       Date:  1991-06       Impact factor: 1.645

8.  Molecular mechanism of the lipid vesicle longevity in vivo.

Authors:  G Blume; G Cevc
Journal:  Biochim Biophys Acta       Date:  1993-03-14

9.  Influence of block copolymers on the adsorption of plasma proteins to microspheres.

Authors:  M E Norman; P Williams; L Illum
Journal:  Biomaterials       Date:  1993-02       Impact factor: 12.479

10.  Serum opsonins and phagocytosis of saturated and unsaturated phospholipid liposomes.

Authors:  S M Moghimi; H M Patel
Journal:  Biochim Biophys Acta       Date:  1989-09-18
View more
  17 in total

1.  Activation of the mononuclear phagocyte system by poloxamine 908: its implications for targeted drug delivery.

Authors:  T I Armstrong; S M Moghimi; S S Davis; L Illum
Journal:  Pharm Res       Date:  1997-11       Impact factor: 4.200

2.  Formulation and antitumor activity evaluation of nanocrystalline suspensions of poorly soluble anticancer drugs.

Authors:  E Merisko-Liversidge; P Sarpotdar; J Bruno; S Hajj; L Wei; N Peltier; J Rake; J M Shaw; S Pugh; L Polin; J Jones; T Corbett; E Cooper; G G Liversidge
Journal:  Pharm Res       Date:  1996-02       Impact factor: 4.200

3.  Branched amphiphilic peptide capsules: cellular uptake and retention of encapsulated solutes.

Authors:  Pinakin Sukthankar; L Adriana Avila; Susan K Whitaker; Takeo Iwamoto; Alfred Morgenstern; Christos Apostolidis; Ke Liu; Robert P Hanzlik; Ekaterina Dadachova; John M Tomich
Journal:  Biochim Biophys Acta       Date:  2014-02-22

4.  Synthesis and bioevaluation of ¹²⁵I-labeled gold nanorods.

Authors:  Xia Shao; Ashish Agarwal; Justin R Rajian; Nicholas A Kotov; Xueding Wang
Journal:  Nanotechnology       Date:  2011-02-22       Impact factor: 3.874

5.  Enhanced passive pulmonary targeting and retention of PEGylated rigid microparticles in rats.

Authors:  Hilliard L Kutscher; Piyun Chao; Manjeet Deshmukh; Sujata Sundara Rajan; Yashveer Singh; Peidi Hu; Laurie B Joseph; Stanley Stein; Debra L Laskin; Patrick J Sinko
Journal:  Int J Pharm       Date:  2010-09-29       Impact factor: 5.875

6.  Modification of the copolymers poloxamer 407 and poloxamine 908 can affect the physical and biological properties of surface modified nanospheres.

Authors:  J C Neal; S Stolnik; M C Garnett; S S Davis; L Illum
Journal:  Pharm Res       Date:  1998-02       Impact factor: 4.200

7.  Prolonged blood circulation in rats of nanospheres surface-modified with semitelechelic poly[N-(2-hydroxypropyl)methacrylamide].

Authors:  S Kamei; J Kopecek
Journal:  Pharm Res       Date:  1995-05       Impact factor: 4.200

8.  Tuning innate immune activation by surface texturing of polymer microparticles: the role of shape in inflammasome activation.

Authors:  Christine A Vaine; Milan K Patel; Jintao Zhu; Eunji Lee; Robert W Finberg; Ryan C Hayward; Evelyn A Kurt-Jones
Journal:  J Immunol       Date:  2013-02-20       Impact factor: 5.422

9.  Pulmonary targeting microparticulate camptothecin delivery system: anticancer evaluation in a rat orthotopic lung cancer model.

Authors:  Piyun Chao; Manjeet Deshmukh; Hilliard L Kutscher; Dayuan Gao; Sujata Sundara Rajan; Peidi Hu; Debra L Laskin; Stanley Stein; Patrick J Sinko
Journal:  Anticancer Drugs       Date:  2010-01       Impact factor: 2.248

10.  The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres.

Authors:  R Gref; A Domb; P Quellec; T Blunk; R H Müller; J M Verbavatz; R Langer
Journal:  Adv Drug Deliv Rev       Date:  1995-09       Impact factor: 15.470

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.